Specialty finance is a purpose-built category of capital solutions designed for businesses whose industries, asset types, or business models require a financing structure that conventional lending products were never designed to provide. It is not a niche workaround or a last resort. In many cases, specialty finance is used by growing businesses whose operating realities simply do not align with conventional underwriting models.
A standard lender declines. A conversation with a capital advisor opens a door not previously visible. For businesses in the right industries, that discovery often reframes the entire financing conversation.
When Standard Financing Does Not Fit
Traditional commercial lending is built around a familiar checklist: stable revenue, tangible assets, two to three years of clean financials, and a borrowing need that maps neatly onto a term loan or revolving credit line. For businesses that match that profile, the system works reasonably well.
For businesses that do not, it tends to produce one of two outcomes. The first is a decline. The second is more costly in the long run: financing that technically gets approved but does not actually fit how the business operates. Wrong repayment structure. Wrong collateral treatment. Covenants built around a business model that does not match the borrower’s reality. That kind of mismatch does not just create inconvenience. It constrains growth and pulls management attention toward a financing relationship that was never properly designed for the situation.
Specialty finance starts from a different question entirely. Not “does this business fit our product?” but “what financing structure actually matches how this business generates and collects value?” The answer looks different across industries, which is exactly the point.
The Industries Where Specialty Finance Shows Up
Healthcare
Medical groups, healthcare providers, and medical staffing firms can be fully operational, billing consistently, and still cash-strapped, not because the business is weak, but because insurance reimbursement takes 60 to 90 days and Medicare and Medicaid cycles add complexity on top of that. The receivables are real. The revenue is real, but conventional lenders see the reimbursement timeline and the adjudication risk and either decline or significantly undervalue the asset. Healthcare-specific financing is built around those realities from the start, allowing providers to access capital against receivables that the generic market consistently misprices.
Litigation and legal finance
Law firms managing contingency practices, litigation finance companies, and legal funding platforms hold real value that does not appear on a balance sheet in a way conventional lenders can evaluate. Litigation finance addresses exactly that gap, allowing firms and businesses to access capital against the expected value of legal outcomes. Lenders who operate in this space understand case timelines, settlement dynamics, and portfolio risk in ways that make the underwriting both credible and practical.
Financial companies and credit platforms
Factoring firms, revenue-based lenders, and other originators face a challenge unique to their situation: they provide financing to their clients but need financing themselves to do it. Conventional banks rarely have the appetite to finance businesses whose assets, revenue streams, or collateral structures fall outside traditional lending models. Specialty finance handles exactly that through lender finance facilities that allow credit platforms to leverage their own performing portfolios.
Transitional real estate and bridge financing
Not all specialty finance is built around receivables and cash flow. Some is built around asset timing. Commercial real estate projects in transition, including lease-up, repositioning, or time-sensitive acquisitions, often fall outside conventional bank underwriting timelines and requirements. Bridge and transitional financing structures are designed for those realities, providing capital aligned with the operational and timing needs of the asset rather than a fully stabilized end state.
The Lender's Expertise Matters as Much as the Rate
In specialty finance, the quality of the financing is directly tied to how well the lender understands the industry. A lender who genuinely knows healthcare reimbursement will build advance rates and eligibility criteria that reflect actual collection performance. One who does not will price conservatively to cover uncertainty, which translates directly into worse terms for the borrower.
And the right financing structure does more than provide liquidity. It supports how a business actually operates.
Finding a lender with genuine industry knowledge is therefore not just about securing a better rate. It is about securing a structure that makes operational sense. The wrong lender in the right category can be just as limiting as the wrong category entirely.
Many Businesses Do Not Know This Exists
The most significant challenge with specialty finance is knowing it exists in the first place. Businesses in industries that specialty finance was built to serve often approach a standard lender, receive a generic product or a decline, and conclude that options are limited. In many cases, they are not. The right capital is simply located in a part of the market in which conventional lenders do not operate.
That gap exists for a straightforward reason. Specialty finance lenders are not generalists. They do not advertise broadly or maintain retail branch networks. They operate in defined verticals and source transactions largely through referrals and advisor relationships. For a business owner without visibility into that part of the market, the category is effectively invisible until someone points to it.
Is Specialty Finance the Right Fit?
The most significant challenge with specialty finance is knowing it exists in the first place. Businesses in industries that specialty finance was built to serve often approach a standard lender, receive a generic product or a decline, and conclude that options are limited. In many cases, they are not. The right capital is simply located in a part of the market in which conventional lenders do not operate.
Many businesses whose industries have financing dynamics that conventional lenders consistently misunderstand are strong candidates for specialty finance. When receivables are routinely undervalued, when revenue is contracted but difficult to pledge as collateral in a conventional sense, or when cash flow timing does not align with standard repayment schedules, the generic lending market might not be built for those situations.
Working with a capital advisor who knows the specialty finance market makes a difference. The value is not just in facilitating a transaction. It is in recognizing which lenders and structures were built for a specific situation, and in knowing how to position a deal to the right part of the market rather than the most obvious one.
i95 Capital works with businesses across specialty finance verticals, structuring custom facilities from $1M to $50M. When conventional financing does not align with how a business or asset actually operates, specialty finance may provide a more effective path forward. Reach out to discuss what a purpose-built capital solution could look like for your situation.